EUVIMEDEUVIMED entdecken
QuerschnittstudieOpen Access

Social Determinants of 6-Mercaptopurine Adherence Among Patients with Acute Lymphoblastic Leukemia/Lymphoma: A Cross-Sectional Analysis

Ayah El-Khatib iD, Kevin Matos, Jenna Rossoff, Alexandra Psihogios iD

Journal of Adolescent and Young Adult Oncology · 2025

DOI: 10.1089/jayao.2024.0119 ↗

Kurz gefasst

Querschnittstudie in der Zeitschrift Journal of Adolescent and Young Adult Oncology, 2025. Verfasst von Ayah El-Khatib und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology, Oncology, and Stem Cell Transplant, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, USA. Hauptthemen laut MEDLINE: Mercaptopurine, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Medication Adherence, Social Determinants of Health. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acute lymphoblastic leukemia requires around 18 months of daily oral chemotherapy called 6-mercaptopurine (6-MP) for treatment. Previous research has included a broad age range and shows adolescent/young adult (AYA) age and minoritized race/ethnicity are associated with lower adherence. Few studies have evaluated how these intersecting identities impact adherence. In a retrospective analysis of an AYA sample, we evaluated the relationships between race/ethnicity, area deprivation index (ADI), and insurance with electronically monitored 6-MP adherence. Results showed minoritized race/ethnicity and ADI correlated with adherence. Findings highlight the need for equitable interventions that enhance adherence and improve outcomes among AYAs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MercaptopurinePrecursor Cell Lymphoblastic Leukemia-LymphomaMedication AdherenceSocial Determinants of HealthAntimetabolites, AntineoplasticHumansFemaleMaleAdolescentCross-Sectional StudiesYoung AdultAdultRetrospective Studies

Stichwörter der Autor:innen

ADISocial determinantsadherenceinsurancerace/ethnicity

Substanzen

MercaptopurineAntimetabolites, Antineoplastic

Autor:innen und Institutionen

  • Division of Hematology, Oncology, and Stem Cell Transplant, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, USA.
  • Department of Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
  • Department of Medical Social Sciences, Northwestern Feinberg School of Medicine, Chicago, Illinois, USA.

ORCID-Profile: Ayah El-Khatib, Alexandra Psihogios

Förderung

  • NCI NIH HHS

Zitieren

APA

El-Khatib, A., Matos, K., Rossoff, J., & Psihogios, A. (2025). Social Determinants of 6-Mercaptopurine Adherence Among Patients with Acute Lymphoblastic Leukemia/Lymphoma: A Cross-Sectional Analysis. Journal of Adolescent and Young Adult Oncology. https://doi.org/10.1089/jayao.2024.0119

Vancouver

El-Khatib A, Matos K, Rossoff J, Psihogios A. Social Determinants of 6-Mercaptopurine Adherence Among Patients with Acute Lymphoblastic Leukemia/Lymphoma: A Cross-Sectional Analysis. Journal of Adolescent and Young Adult Oncology. 2025. doi:10.1089/jayao.2024.0119

BibTeX
@article{ElKhatib2025,
  author = {El-Khatib, Ayah and Matos, Kevin and Rossoff, Jenna and Psihogios, Alexandra},
  title = {Social Determinants of 6-Mercaptopurine Adherence Among Patients with Acute Lymphoblastic Leukemia/Lymphoma: A Cross-Sectional Analysis},
  journal = {Journal of Adolescent and Young Adult Oncology},
  year = {2025},
  doi = {10.1089/jayao.2024.0119}
}
Kostenlos starten →